BackAcorda Therapeutics Overview

Acorda Therapeutics Selling, General & Admin

Selling, General & Admin expenses for ACOR.

Quarterly SG&A Expenses

$28.37M
↑ 26.01% YoY

As of Mar 31, 2024

Annual SG&A Expenses (TTM)

$95.55M
↓ 6.17% YoY

Trailing 12 months ending Mar 31, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin